Envestnet Asset Management
MDGL icon

Envestnet Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Envestnet Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.66M Sell
14,263
-1,198
-8% -$614K ﹤0.01% 2135
2026
Q1 		$8.09M Buy
15,461
+89
+0.6% +$42.5K ﹤0.01% 1975
2025
Q4 		$8.95M Buy
15,372
+806
+6% +$412K ﹤0.01% 1770
2025
Q3 		$6.68M Buy
14,566
+64
+0.4% +$23.9K ﹤0.01% 2036
2025
Q2 		$4.39M Sell
14,502
-768
-5% -$229K ﹤0.01% 2276
2025
Q1 		$5.06M Buy
15,270
+269
+2% +$88.4K ﹤0.01% 2117
2024
Q4 		$4.63M Buy
15,001
+334
+2% +$93.9K ﹤0.01% 2154
2024
Q3 		$3.11M Buy
14,667
+213
+1% +$54.5K ﹤0.01% 2392
2024
Q2 		$4.05M Buy
14,454
+9,616
+199% +$2.29M ﹤0.01% 2169
2024
Q1 		$1.29M Sell
4,838
-103
-2% -$24.3K ﹤0.01% 2855
2023
Q4 		$1.14M Buy
4,941
+708
+17% +$124K ﹤0.01% 2842
2023
Q3 		$618K Buy
4,233
+1,981
+88% +$373K ﹤0.01% 3135
2023
Q2 		$520K Buy
2,252
+432
+24% +$117K ﹤0.01% 3183
2023
Q1 		$441K Buy
1,820
+539
+42% +$147K ﹤0.01% 3226
2022
Q4 		$372K Buy
+1,281
New +$125K ﹤0.01% 3283
2013
Q4 		– Sell
-58
Closed -$13K – 2509
2013
Q3 		$13K Buy
+58
New +$12.3K ﹤0.01% 1614

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Envestnet Asset Management's MDGL Position: Q2 2026 in Review

Envestnet Asset Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 7.7% in Q2 2026, selling an estimated $614K and leaving 14,263 shares worth $7.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2135.

Envestnet Asset Management first reported a position in MDGL in Q3 2013 and has held it in 16 quarters since. The position peaked at $8.95M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Envestnet Asset Management held 14,263 shares of Madrigal Pharmaceuticals worth $7.66M as of Q2 2026.
  • Envestnet Asset Management sold 1,198 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $614K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2135 holding.
  • Envestnet Asset Management first reported a position in Madrigal Pharmaceuticals in Q3 2013 and has held it in 16 quarters since.
  • Envestnet Asset Management's Madrigal Pharmaceuticals position peaked at $8.95M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.